BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND ABL1, p150, 25, ENSG00000097007, P00519, v-abl, bcr/abl, JTK7, c-ABL, ABL, BCR-ABL AND Treatment
2981 results:

  • 1. Beyond Clinical Trials: Understanding Neurotrophic Tropomyosin Receptor Kinase Inhibitor Challenges and Efficacy in Real-World Pediatric Oncology.
    Vince CSC; Brassesco MS; Mançano BM; Gregianin LJ; Carbone EK; do Amaral E Castro A; Dwan VSY; Menezes da Silva RZ; Mariano CS; da Mata JF; Silva MO; Caran EMM; Macedo CD; Alves da Costa G; Esteves TC; Silva LN; Ferman SE; Martins FD; Cristófani LM; Odone-Filho V; Silva MM; Reis RM; Pianovski MAD; Campregher PV; Kunii MS; de Sá Rodrigues KE; Carvalho Filho NP; Valera ET;
    JCO Precis Oncol; 2024 May; 8():e2300713. PubMed ID: 38810175
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A Systemic Review of Primary Malignant Long Bone Tumors in Children and Adolescents.
    Khan M; Patel R; Youssef M; Banerjee R; Pardiwala A; Belen C
    Acta Chir Orthop Traumatol Cech; 2024; 91(2):77-87. PubMed ID: 38801663
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Glycolic acid and D-lactate-putative products of DJ-1-restore neurodegeneration in FUS - and SOD1-ALS.
    Pal A; Grossmann D; Glaß H; Zimyanin V; Günther R; Catinozzi M; Boeckers TM; Sterneckert J; Storkebaum E; Petri S; Wegner F; Grill SW; Pan-Montojo F; Hermann A
    Life Sci Alliance; 2024 Aug; 7(8):. PubMed ID: 38760174
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Navigating diagnostic challenges-distinguishing malignant melanoma and clear cell sarcoma of soft tissues: a case report and review of the literature.
    Abdouh S; Boujguenna I; Soleh A; Abkari I; Rais H
    J Med Case Rep; 2024 May; 18(1):249. PubMed ID: 38755643
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. First-line avelumab treatment in patients with metastatic Merkel cell carcinoma: 4-year follow-up from part B of the JAVELIN Merkel 200 study.
    D'Angelo SP; Lebbé C; Mortier L; Brohl AS; Fazio N; Grob JJ; Prinzi N; Hanna GJ; Hassel JC; Kiecker F; von Heydebreck A; Güzel G; Nghiem P
    ESMO Open; 2024 May; 9(5):103461. PubMed ID: 38744102
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. COLUMBUS 7-year update: A randomized, open-label, phase III trial of encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF V600E/K-mutant melanoma.
    Schadendorf D; Dummer R; Flaherty KT; Robert C; Arance A; de Groot JWB; Garbe C; Gogas HJ; Gutzmer R; Krajsová I; Liszkay G; Loquai C; Mandalà M; Yamazaki N; Queirolo P; Guenzel C; Polli A; Thakur M; di Pietro A; Ascierto PA
    Eur J Cancer; 2024 Jun; 204():114073. PubMed ID: 38723373
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Epidemiology, treatment and outcomes of primary renal sarcomas in adult patients.
    Uhlig J; Uhlig A; Deshpande H; Ströbel P; Trojan L; Lotz J; Hurwitz M; Hafez O; Humphrey P; Grünwald V; Kim HS
    Sci Rep; 2024 May; 14(1):10038. PubMed ID: 38693188
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinoma: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology.
    Queirolo P; Cinquini M; Argenziano G; Bassetto F; Bossi P; Boutros A; Clemente C; de Giorgi V; Del Vecchio M; Patuzzo R; Pennachioli E; Peris K; Quaglino P; Reali A; Zalaudek I; Spagnolo F
    ESMO Open; 2024 May; 9(5):103005. PubMed ID: 38688192
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Prognostic Factors Associated with Tumor Recurrence and Overall Survival in Soft Tissue sarcomas of the Extremities in a Colombian Reference Cancer Center.
    Díaz Casas SE; Villacrés JM; Lehmann Mosquera C; García Mora M; Mariño Lozano I; Ángel Aristizábal J; Suarez Rodríguez R; Duarte Torres CA; Sánchez Pedraza R
    Curr Oncol; 2024 Mar; 31(4):1725-1738. PubMed ID: 38668034
    [No Abstract]    [Full Text] [Related]  

  • 10. Associations Between Stress, Health Behaviors, and Quality of Life in Young Couples During the Transition to Survivorship: Protocol for a Measurement Burst Study.
    Cho D; Roth M; Peterson SK; Jennings K; Kim S; Weathers SP; Ahmed S; Livingston JA; Barcenas C; You YN; Milbury K
    JMIR Res Protoc; 2024 Apr; 13():e53307. PubMed ID: 38652520
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Sarcoma of the uterine cervix: experience of a single center.
    Yuan H; Li L; Li N; Yao H
    World J Surg Oncol; 2024 Apr; 22(1):104. PubMed ID: 38637834
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Functional and oncological outcomes of patients with proximal humerus osteosarcoma managed by limb salvage.
    Sadek WMS; Elshamly IKF; Salem MSM; AbouSenna WG; Ebeid E; Ebeid WA
    J Orthop Traumatol; 2024 Apr; 25(1):18. PubMed ID: 38637478
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Extrapleural pneumonectomy for sarcoma: Outcomes of adult patients at a specialized center.
    Zhang BY; Wilson-Smith AR; Connolly EA; Strach MC; Ussher N; Yan T; Bhadri VA
    Cancer Rep (Hoboken); 2024 Apr; 7(4):e2065. PubMed ID: 38627902
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. treatment Monitoring of a Patient with Synchronous Metastatic Angiosarcoma and Breast Cancer Using ctDNA.
    Vannas C; Escobar M; Österlund T; Andersson D; Mouhanna P; Soomägi A; Molin C; Wennergren D; Fagman H; Ståhlberg A
    Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612833
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Habitat escalated adaptive therapy (HEAT): a phase 2 trial utilizing radiomic habitat-directed and genomic-adjusted radiation dose (GARD) optimization for high-grade soft tissue sarcoma.
    Naghavi AO; Bryant JM; Kim Y; Weygand J; Redler G; Sim AJ; Miller J; Coucoules K; Michael LT; Gloria WE; Yang G; Rosenberg SA; Ahmed K; Bui MM; Henderson-Jackson EB; Lee A; Lee CD; Gonzalez RJ; Feygelman V; Eschrich SA; Scott JG; Torres-Roca J; Latifi K; Parikh N; Costello J
    BMC Cancer; 2024 Apr; 24(1):437. PubMed ID: 38594603
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Comprehensive Transcriptomic Analysis of EWSR1::WT1 Targets Identifies CDK4/6 Inhibitors as an Effective Therapy for Desmoplastic Small Round Cell Tumors.
    Magrath JW; Sampath SS; Flinchum DA; Hartono AB; Goldberg IN; Boehling JR; Savkovic SD; Lee SB
    Cancer Res; 2024 May; 84(9):1426-1442. PubMed ID: 38588409
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Artificial intelligence large language model ChatGPT: is it a trustworthy and reliable source of information for sarcoma patients?
    Valentini M; Szkandera J; Smolle MA; Scheipl S; Leithner A; Andreou D
    Front Public Health; 2024; 12():1303319. PubMed ID: 38584922
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Impact assessment of integrated-pathy on cancer-related fatigue in cancer patients: an observational study.
    Balkrishna A; Katiyar P; Ghosh S; Singh SK; Arya V
    J Health Popul Nutr; 2024 Apr; 43(1):48. PubMed ID: 38576058
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A Single-center Experience of Radiotherapy in Pediatric Ewing Sarcoma/Primitive Neuroectodermal Tumor of the Chest Wall.
    Yigit E; Gultekin M; Aydin B; Kutluk T; Yuce Sari S; Ekinci S; Orhan D; Yildiz F
    J Pediatr Hematol Oncol; 2024 May; 46(4):197-205. PubMed ID: 38572993
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial.
    D'Angelo SP; Araujo DM; Abdul Razak AR; Agulnik M; Attia S; Blay JY; Carrasco Garcia I; Charlson JA; Choy E; Demetri GD; Druta M; Forcade E; Ganjoo KN; Glod J; Keedy VL; Le Cesne A; Liebner DA; Moreno V; Pollack SM; Schuetze SM; Schwartz GK; Strauss SJ; Tap WD; Thistlethwaite F; Valverde Morales CM; Wagner MJ; Wilky BA; McAlpine C; Hudson L; Navenot JM; Wang T; Bai J; Rafail S; Wang R; Sun A; Fernandes L; Van Winkle E; Elefant E; Lunt C; Norry E; Williams D; Biswas S; Van Tine BA
    Lancet; 2024 Apr; 403(10435):1460-1471. PubMed ID: 38554725
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 150.